Impact of Treatment With Oral Anticoagulants of Patients With Fractures of the Upper End of the Femur

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

610 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In 2023, oral anticoagulant treatments (anti Xa: apixaban , rivaroxaban, etc.) are tending to replace anti vitamin K treatments in many medical indications. Their prescription is increasing rapidly in the elderly.

In this context, the Nimes University Hospital receives a large number of elderly patients who have suffered a fracture of the end of the femur requiring surgery and who are taking anti Xa drugs.To avoid massive intra- and post-operative haemorrhage, surgical management is postponed because of the need to suspend the treatment, allowing a return to near-normal biological haemostasis within a few days. No consensus has been reached on the withdrawal period required to authorise surgery, as the elimination kinetics of the drug are altered in this context (elderly patients, dehydration, hypovolaemia, impaired renal function). A plasma assay (threshold of \<30 to 60 ng/mL) has been proposed without any real justification. This waiting period exposes the elderly to excess mortality. Reversing these treatments by adding coagulation factors would be an attractive alternative, as it would allow surgery to be performed earlier, but this would expose patients to an increased thrombotic risk.

Before considering a prospective randomised study (early vs delayed surgery on AOD), we wish to retrospectively analyse data on patients admitted to the Nimes University Hospital on anti Xa and operated on for fracture of the upper end of the femur between 1 January 2022 and 1 June 2023

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

NCT03157154

Hemophilia

COMPLETED

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

NCT01722786

Severe Bleeding Urgent Surgery

COMPLETED

Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients

NCT02964546

Atrial Fibrillation Elderly Patients Chronic Kidney Disease

TERMINATED

Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs

NCT03634124

Deep Vein Thrombosis Total Hip Prosthesis Knee Prosthesis

COMPLETED PHASE3

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

NCT00353678

Thromboembolism

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Direct Oral Anticoagulants (DOACs) Femoral Fractures Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anti XA

adults treated with direct oral factor Xa inhibitors undergoing Femoral head fracture surgery

Femoral fracture surgery

Intervention Type PROCEDURE

Hip fracture surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Femoral fracture surgery

Hip fracture surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient \> 65 years
* Emergency admission for isolated fracture of the upper end of the femur
* Requires osteosynthesis surgery
* Hospitalized in geriatric perioperative unit, chu Nimes (UPOG)
* On anti Xa therapy prior to hospitalisation

Exclusion Criteria

* Patients under court order or not affiliated to a social security scheme
* Outpatient surgery
* Multiple fractures and/or other associated surgery
* Not admitted to UPOG
* No surgery

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No